• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的大动脉炎疾病活动评估工具的推导和验证,具有更高的准确性。

Derivation and Validation of a New Disease Activity Assessment Tool With Higher Accuracy for Takayasu Arteritis.

机构信息

Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

出版信息

Front Immunol. 2022 Jun 17;13:925341. doi: 10.3389/fimmu.2022.925341. eCollection 2022.

DOI:10.3389/fimmu.2022.925341
PMID:35784279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9248800/
Abstract

OBJECTIVE

To develop a new disease activity assessment tool with high accuracy for Takayasu arteritis.

METHODS

Individual items from National Institute of Health (NIH) criteria and the Indian Takayasu Clinical Activity Score (ITAS2010) were tested as candidate variables to develop a new disease activity assessment tool in a derivation cohort (N = 100). Physician global assessment on disease activity was used as the gold standard. Multivariable logistic regression models were constructed and the model with the highest accuracy was identified. A formula assessing disease activity was generated using simplified β coefficients (rounded to decimal place). Diagnostic performance was evaluated through estimating the area under the curve (AUC). The new assessment tool was subsequently validated in a validation cohort (N = 46).

RESULTS

The multivariable model yielding the highest accuracy consisted of a high erythrocyte sedimentation rate (ESR), NIH criteria 1 and 4, and carotidynia. Using simplified β coefficients, the following disease activity assessment tool was developed: high ESR (3 points), NIH criterion 1 (2 points), NIH criterion 4 (4 points), and carotidynia (3 points) (total score ≥5, active; total score <5, inactive). The new disease activity assessment tool had a higher AUC (89.37) for discriminating active and inactive diseases than NIH criteria (AUC 77.96), ITAS2010 (AUC 66.12), ITAS-ESR (AUC 75.58), and ITAS-C-reactive protein (AUC 71.34). The AUC (85.23) of the new assessment tool was similar in the validation cohort.

CONCLUSION

A new disease activity assessment tool that consists of high ESR, NIH criteria 1 and 4, and carotidynia had higher accuracy in discriminating active and inactive disease than currently used clinical assessment tools.

摘要

目的

开发一种新的大动脉炎疾病活动评估工具,具有较高的准确性。

方法

从国立卫生研究院(NIH)标准和印度大动脉炎临床活动评分(ITAS2010)中选择个体项目作为候选变量,在推导队列(N=100)中开发一种新的疾病活动评估工具。医生对疾病活动的整体评估被用作金标准。构建多变量逻辑回归模型,并确定准确性最高的模型。使用简化的β系数(四舍五入到小数点后一位)生成评估疾病活动的公式。通过估计曲线下面积(AUC)来评估诊断性能。随后在验证队列(N=46)中验证新的评估工具。

结果

产生最高准确性的多变量模型由高红细胞沉降率(ESR)、NIH 标准 1 和 4 以及颈动脉痛组成。使用简化的β系数,开发了以下疾病活动评估工具:高 ESR(3 分)、NIH 标准 1(2 分)、NIH 标准 4(4 分)和颈动脉痛(3 分)(总分≥5 分,活动;总分<5 分,不活动)。新的疾病活动评估工具在区分活动和不活动疾病方面的 AUC(89.37)高于 NIH 标准(AUC 77.96)、ITAS2010(AUC 66.12)、ITAS-ESR(AUC 75.58)和 ITAS-C 反应蛋白(AUC 71.34)。新评估工具在验证队列中的 AUC(85.23)相似。

结论

一种新的疾病活动评估工具,由高 ESR、NIH 标准 1 和 4 以及颈动脉痛组成,在区分活动和不活动疾病方面的准确性高于目前使用的临床评估工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a2/9248800/b62a2282f8a7/fimmu-13-925341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a2/9248800/b62a2282f8a7/fimmu-13-925341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a2/9248800/b62a2282f8a7/fimmu-13-925341-g001.jpg

相似文献

1
Derivation and Validation of a New Disease Activity Assessment Tool With Higher Accuracy for Takayasu Arteritis.一种新的大动脉炎疾病活动评估工具的推导和验证,具有更高的准确性。
Front Immunol. 2022 Jun 17;13:925341. doi: 10.3389/fimmu.2022.925341. eCollection 2022.
2
Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).印度大动脉炎临床活动评分(ITAS2010)的制定与初步验证。
Rheumatology (Oxford). 2013 Oct;52(10):1795-801. doi: 10.1093/rheumatology/ket128. Epub 2013 Apr 16.
3
Assessment of Patients with Takayasu Arteritis in Routine Practice with Indian Takayasu Clinical Activity Score.采用印度大动脉炎临床活动评分对大动脉炎患者进行常规评估。
J Rheumatol. 2015 Aug;42(8):1443-7. doi: 10.3899/jrheum.140817. Epub 2015 Jul 1.
4
NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.基于 NMR 的大动脉炎患者血清代谢组学:与疾病活动的关系。
J Proteome Res. 2018 Sep 7;17(9):3317-3324. doi: 10.1021/acs.jproteome.8b00456. Epub 2018 Aug 24.
5
Translation and validation of the Indian Takayasu clinical activity score (ITAS2010) for the Brazilian Portuguese language.印度大动脉炎临床活动评分(ITAS2010)的巴西葡萄牙语翻译与验证。
Adv Rheumatol. 2019 Oct 16;59(1):43. doi: 10.1186/s42358-019-0087-3.
6
Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.血清25-羟维生素D升高:红细胞沉降率和C反应蛋白水平正常的大动脉炎患者缓解的潜在指标。
Clin Rheumatol. 2024 Jun;43(6):1979-1987. doi: 10.1007/s10067-024-06957-w. Epub 2024 Apr 10.
7
Contrast-enhanced ultrasound for evaluating arteritis activity in Takayasu arteritis patients.对比增强超声用于评估 Takayasu 动脉炎患者的动脉炎活动度。
Clin Rheumatol. 2020 Apr;39(4):1229-1235. doi: 10.1007/s10067-019-04698-9. Epub 2019 Aug 20.
8
Pentraxin-3 as a marker of disease activity in Takayasu arteritis.血清淀粉样蛋白 P 成分 3 作为大动脉炎疾病活动的标志物。
Ann Intern Med. 2011 Oct 4;155(7):425-33. doi: 10.7326/0003-4819-155-7-201110040-00005.
9
Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis.血清补体 3 是评估大动脉炎疾病活动的潜在生物标志物。
Arthritis Res Ther. 2021 Feb 24;23(1):63. doi: 10.1186/s13075-021-02433-x.
10
Circulatory Glutamine/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study.基于 NMR 的血清代谢组学研究:循环谷氨酰胺/葡萄糖比值用于评估大动脉炎的疾病活动度。
J Pharm Biomed Anal. 2020 Feb 20;180:113080. doi: 10.1016/j.jpba.2019.113080. Epub 2019 Dec 24.

本文引用的文献

1
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.2021 年美国风湿病学会/脉管炎基金会巨细胞动脉炎和 Takayasu 动脉炎管理指南。
Arthritis Rheumatol. 2021 Aug;73(8):1349-1365. doi: 10.1002/art.41774. Epub 2021 Jul 8.
2
Takayasu Arteritis: a Systematic Review and Meta-Analysis of Test Accuracy and Benefits and Harms of Common Treatments.高安动脉炎:常见治疗方法的检测准确性、益处及危害的系统评价与荟萃分析
ACR Open Rheumatol. 2021 Feb;3(2):80-90. doi: 10.1002/acr2.11186. Epub 2021 Jan 29.
3
Assessment of inflammatory activity in Takayasu's arteritis: performance of clinical scores and common biomarkers versus 18F-FDG PET/CT.
Takayasu 动脉炎炎症活动评估:临床评分和常见生物标志物与 18F-FDG PET/CT 的比较。
Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1011-1020. doi: 10.55563/clinexprheumatol/a71bzh. Epub 2020 Oct 29.
4
An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu's arteritis.18F-FDG-PET/CT 显示 NIH 标准下不活动的 Takayasu 动脉炎患者大血管摄取增加。
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):88-92. Epub 2018 Feb 7.
5
F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis.氟代脱氧葡萄糖正电子发射断层扫描作为大血管血管炎前瞻性纵向队列患者的影像学生物标志物。
Arthritis Rheumatol. 2018 Mar;70(3):439-449. doi: 10.1002/art.40379. Epub 2018 Feb 6.
6
F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis.氟代脱氧葡萄糖正电子发射断层扫描(F-FDG PET)揭示了大动脉炎患者大血管炎症的独特特征。
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1109-1118. doi: 10.1007/s00259-017-3639-y. Epub 2017 Feb 8.
7
Evidence Based Emergency Medicine; Part 5 Receiver Operating Curve and Area under the Curve.循证急诊医学;第5部分 受试者工作特征曲线及曲线下面积
Emerg (Tehran). 2016 Spring;4(2):111-3.
8
Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.日本跨国研究观察到的新 Takayasu 动脉炎患者的当前临床特征:年龄和性别特异性。
Circulation. 2015 Nov 3;132(18):1701-9. doi: 10.1161/CIRCULATIONAHA.114.012547. Epub 2015 Sep 9.
9
Assessment of Patients with Takayasu Arteritis in Routine Practice with Indian Takayasu Clinical Activity Score.采用印度大动脉炎临床活动评分对大动脉炎患者进行常规评估。
J Rheumatol. 2015 Aug;42(8):1443-7. doi: 10.3899/jrheum.140817. Epub 2015 Jul 1.
10
Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.大血管血管炎疗效评估指标发展的最新情况:OMERACT 12报告
J Rheumatol. 2015 Dec;42(12):2465-9. doi: 10.3899/jrheum.141144. Epub 2015 Jun 15.